Topic 377: Symptom Management and Intervention Roadmaps (STaIRS)

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 75N91018C00021-0-0-0
Agency Tracking Number: N43CA180021
Amount: $225,000.00
Phase: Phase I
Program: SBIR
Solicitation Topic Code: NCI
Solicitation Number: N/A
Timeline
Solicitation Year: 2017
Award Year: 2018
Award Start Date (Proposal Award Date): N/A
Award End Date (Contract End Date): N/A
Small Business Information
11900 Biscayne Blvd, NORTH MIAMI, FL, 33181
DUNS: 080354635
HUBZone Owned: N
Woman Owned: Y
Socially and Economically Disadvantaged: N
Principal Investigator
 Carrie Stricker
 (305) 979-0068
 carrie@carevive.com
Business Contact
 Carrie Stricker
Phone: (305) 979-0068
Email: carrie@carevive.com
Research Institution
N/A
Abstract
Numerous adverse symptoms are under-detected in cancer care resulting1-3 in missed opportunities for intervention; leading to poor treatment adherence, avoidable hospitalizations, and worse morbidity and survival. The IOM proposed shaking up the current symptom paradigm from reactive to proactive, personalized, technology-enabled models of symptom care as a solution to this clinical quality crisis. Such proactive care models reduce symptom burden, emergency department use, and improve survival. While commercially-available symptom monitoring and clinical alerting applications proliferate, they lack personalized, computable algorithms for tailored, evidence-based clinical symptom management. The Carevive Care Planning System (CPS) is an exception, having commercially deployed symptom monitoring and assessment tools, clinician-facing content, and computable algorithms for patient self-management of symptoms since 2014, via a proprietary rules engine. These assets, combined with ONS content and Carevive's extensive network of expert advisors and clients, will be leveraged in Phase I into the usercentered design of computable algorithms for clinician assessment and management of fatigue and constipation; integrating clinical data to facilitate personalized, evidence-based symptom care superior to existing reactive and proactive symptom care approaches. Phase I wireframes will be the basis for symptom expansion, extensive usability and field testing in Phase II, and ultimately efficacy testing and full-scale commercialization.

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government